| Value | ₹22.71 Cr |
|---|
BSE filing, NSE: SHARIKA. Summary written from the filing by ALFA Finder's alert engine.
Sharika Enterprises Ltd: key numbers
- Share price
- ₹16.99
- Market cap
- ₹73.57 Cr
- Revenue (annual)
- ₹75.46 Cr
- Net profit (annual)
- ₹-8.85 Cr
- P/E (TTM)
- -9.0×Sector 45.0×
- Promoter holding
- 43.04%-12.12% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sharika Enterprises Ltd
All →Sharika Enterprises Other Announcement
Sharika Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Sharika Enterprises Other Announcement
Sharika Enterprises Ltd has filed its quarterly shareholding pattern. This document provides a breakdown of shareholding across various categories for the relevant period.
Sharika Enterprises Promoter Buying (Off-Market): ₹0.38 Cr
Sharika Enterprises Ltd's promoters and directors acquired warrants via preferential offer. The total transaction value across individuals is ₹0.38 Crore.
- Value
- ₹0.38 Cr
Sharika Enterprises Capital Structure Change
Promoters of Sharika Enterprises Limited acquired 10,67,725 convertible warrants via a preferential allotment. This represents 1.83% of the diluted share capital of the company.
Sharika Enterprises Annual General Meeting
Sharika Enterprises Limited held its 28th Annual General Meeting on September 28, 2026. Shareholders approved the annual financial statements and managerial remuneration for two directors.
Sharika Enterprises Capital Structure Change
Sharika Enterprises allotted 1.22 crore equity shares and 28.12 lakh warrants via a preferential issue. The total consideration for this capital raise is approximately Rs. 215.11 Crore.
- Value
- ₹17.47 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr